Drugs / fecal microbiota transplantation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05608447 Comparator | Jan → Jun 2023 | essential hypertension | Chinese Academy of Medical Sciences, Fuwai Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota transplantation | “This study will perform intense fecal microbiota transplantation (FMT) intervention via oral capsules, in comparison with placebo capsules, to investigate the effect, safety...” NCT05608447 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05608447 ↗ |
| Route | Oral | “FMT intervention via oral capsules” NCT05608447 ↗ |